Link Asia International MedTech : INSIDE INFORMATION; DELAY IN PUBLICATION OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020; AND POSTPONEMENT OF BOARD MEETING

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Link-Asia International MedTech Group Limited

環 亞 國 際 醫 療 科 技 集 團 有 限 公 司

(incorporated in the Cayman Islands with limited liability)

(Stock code: 1143)

INSIDE INFORMATION;

DELAY IN PUBLICATION OF ANNUAL RESULTS

FOR THE YEAR ENDED 31 DECEMBER 2020; AND

POSTPONEMENT OF BOARD MEETING

This announcement is made by Link-Asia International MedTech Group Limited (the ''Company'', together with its subsidiaries, the ''Group'') pursuant to Rule 13.09 of the Rules Governing the Listing of Securities (the ''Listing Rules'') on The Stock Exchange of Hong Kong Limited (the ''Stock Exchange'') and Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

DELAY IN PUBLICATION OF ANNUAL RESULTS

The board (''Board'') of directors of the Company wishes to inform the shareholders of the Company (the ''Shareholders'') that there will be a delay in the release of the annual results for the year ended 31 December 2020 (the ''2020 Annual Results''). The main reason is that the outbreak of COVID-19 in various countries and the anti-pandemic measures for the prevention and control of COVID-19 implemented have caused difficulties on the auditing and reporting process of the Company's operations, particularly those located in France, Thailand, the Philippines and part of China, which resulted in the auditors of the Company (the ''Auditors'') being unable to obtain all necessary documents and/or information including but not limited to audit confirmation letters and audit verification information from Thailand and part of China on time to enable them to finish the audit verification procedures and issue the 2020 Annual Results on or before 31 March 2021.

Pursuant to Rules 13.49(1) of the Listing Rules, the Company is required to publish the 2020 Annual Results on or before 31 March 2021. The delay in publication of the 2020 Annual Results constitutes non-compliance of Rules 13.49(1) of the Listing Rules.

- 1 -

Discussions with the Auditors are ongoing and the Board and the management of the Company are doing their utmost to assist and cooperate with the Auditors so that the 2020 Annual Results can be available as soon as practicable. It is expected that the publication of the 2020 Annual Results will be postponed to on or about 9 April 2021. Notwithstanding the delay in publication of the 2020 Annual Results, the Board wishes to emphasize that the operation of the Company and its subsidiaries remain normal and that it will continue to work with the Auditors closely with a view to publish the 2020 Annual Results as soon as possible.

PUBLICATION OF UNAUDITED ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020

Rule 13.49(3) of the Listing Rules provides that where an issuer is unable to issue its preliminary results, it must announce its results based on the financial results which have yet to be agreed with the auditor (so far as the information is available). In order to keep the Shareholders and potential investors informed of the Group's business operations and financial position, the Board will review and approve, among other things, the publication of the unaudited annual results of the Company for the year ended 31 December 2020 (the ''2020 Unaudited Annual Results'') on 31 March 2021. The Company will publish further announcement in relation to the 2020 Unaudited Annual Results as and when appropriate.

POSTPONEMENT OF BOARD MEETING

Reference is made to the announcement of the Company dated 17 March 2021. As a result of the delay in the publication of the 2020 Annual Results, the Board meeting proposed to be held on 31 March 2021 for the purpose to, among other things, consider and approve the 2020 Annual Results, has been postponed.

FURTHER ANNOUNCEMENT(S)

The Company will publish further announcement(s) to inform Shareholders and potential investors any material developments in connection with the above matters as and when appropriate.

Shareholders and potential investors of the Company should exercise caution when dealing in the shares of the Company.

On behalf of the Board

Link-Asia International MedTech Group Limited

Lin Dailian

Chairman and executive Director

Hong Kong, 31 March 2021

As at the date of this announcement, the Board comprises Mr. Lin Dailian (Chairman), Mr. Wang Guozhen, Mr. Duan Chuanhong and Mr. Xia Xiaobing as executive Directors; Mr. Li Huiwu, Mr. Yang Weidong and Dr. Sun Xiaohu as independent non-executive Directors.

- 2 -